| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Thrombin time
Test CodeTCT
Alias/See Also
AZ and WD locations Performed at Sonora Quest Laboratories, Test Code 3520
BUMCT and BUMCS performed at BUMCT
Thrombin Clotting Time
BUMCT and BUMCS performed at BUMCT
Thrombin Clotting Time
CPT Codes
85670
Preferred Specimen
2.7 mL full light blue-top (3.2% Na citrate) tube. Centrifuge without delay. Transfer only top 2/3 of plasma (plasma must be platelet free) into a plastic vial (a minimum of 1.0 mL). If other coagulation tests are ordered, freeze a minimum of two plastic vials. Freeze immediately. Place in a specimen bag with a frozen label applied.
BUMCT- 2.7 mL full light blue-top (3.2% Na citrate) tube. Centrifuge within 1 hour of collection. If testing is not complete within 4 hours of collection use double spin technique to remove plasma (use plastic transfer pipette to remove plasma, transfer to plastic tube, re-spin plasma, transfer to fresh plastic tube) Freeze at -20°C
BUMCT- 2.7 mL full light blue-top (3.2% Na citrate) tube. Centrifuge within 1 hour of collection. If testing is not complete within 4 hours of collection use double spin technique to remove plasma (use plastic transfer pipette to remove plasma, transfer to plastic tube, re-spin plasma, transfer to fresh plastic tube) Freeze at -20°C
Instructions
For other Az facilities besides BUMCT or BUMCS, see link below for specimen details, methodology, setup schedule and reference ranges for testing performed at SQL.
Transport Temperature
frozen - use dry ice (BUMCT)
Specimen Stability
| Specimen Stability: Plasma stability (BUMCT) |
| · 4 hours at 2-8°C or 20°C |
| · <2 weeks at <-20°C to -50°C |
| · <6 months frozen at -50 to -70°C |
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
| Rejection Criteria: (BUMCT) |
| · clotted specimens |
| · underfilled or overfilled tube |
| · collection in 3.8% Citrate |
| · specimens collected in expired tubes |
| · serum samples |
| · specimen past stability |
| · thawed frozen samples |
| · Hemolyzed, Icteric and Lipemic samples |
| · HCT >55% |
Clinical Significance
This test is typically used for the evaluation of Disseminated Intravascular Coagulation (DIC), monitoring heparin anticoagulant and fibrinolytic therapy, detection of the presence of Fibrin/Fibrinogen Degradation Products (FDP), hereditary or acquired qualitative and quantitative fibrinogen abnormalities and increased fibrinolysis.
Additional Information
Thrombin Time

